CL2016001350A1 - Composiciones de ketoprofeno de accion prologanda. - Google Patents
Composiciones de ketoprofeno de accion prologanda.Info
- Publication number
- CL2016001350A1 CL2016001350A1 CL2016001350A CL2016001350A CL2016001350A1 CL 2016001350 A1 CL2016001350 A1 CL 2016001350A1 CL 2016001350 A CL2016001350 A CL 2016001350A CL 2016001350 A CL2016001350 A CL 2016001350A CL 2016001350 A1 CL2016001350 A1 CL 2016001350A1
- Authority
- CL
- Chile
- Prior art keywords
- action
- proto
- ketoprofen compositions
- ketoprofen
- compositions
- Prior art date
Links
- 229960000991 ketoprofen Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- -1 KETOPROPHEN ESTER Chemical class 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
COMPOSICIÓN VETERINARIA DE ACCIÓN PROLONGADA QUE COMPRENDE UN PROFÁRMACO DE ÉSTER DE KETOPROFENO, AL MENOS UN TRIGLICÉRIDO, UN CONSERVANTE Y OPCIONALMENTE AL MENOS UN EXCIPIENTE ADICIONAL; Y USO EN FORMA DE INYECTABLE PARA EL TRATAMIENTO DEL DOLOR, FIEBRE Y/O LA INFLAMACIÓN.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361916462P | 2013-12-16 | 2013-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2016001350A1 true CL2016001350A1 (es) | 2016-11-25 |
Family
ID=52347413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2016001350A CL2016001350A1 (es) | 2013-12-16 | 2016-06-02 | Composiciones de ketoprofeno de accion prologanda. |
Country Status (16)
Country | Link |
---|---|
US (1) | US10632095B2 (es) |
EP (1) | EP3082762B1 (es) |
JP (2) | JP6306188B2 (es) |
KR (1) | KR101817028B1 (es) |
CN (2) | CN112843042A (es) |
AU (1) | AU2014366221C1 (es) |
CA (1) | CA2931858C (es) |
CL (1) | CL2016001350A1 (es) |
DK (1) | DK3082762T3 (es) |
ES (1) | ES2901706T3 (es) |
MX (1) | MX2016007869A (es) |
NZ (1) | NZ719783A (es) |
PH (1) | PH12016500910A1 (es) |
PL (1) | PL3082762T3 (es) |
RU (1) | RU2646829C1 (es) |
WO (1) | WO2015095045A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2016007869A (es) * | 2013-12-16 | 2016-10-07 | Zoetis Services Llc | Composiciones de ketoprofeno de accion prolongada. |
US9714403B2 (en) | 2014-06-19 | 2017-07-25 | E I Du Pont De Nemours And Company | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
CA3085488A1 (en) * | 2017-12-11 | 2019-06-20 | Meat & Livestock Australia Ltd | Transdermal analgesic formulation |
WO2020041658A1 (en) * | 2018-08-24 | 2020-02-27 | Centrexion Therapeutics Corporation | Capsaicin sequential dosing method for treatment of knee joint pain |
CN115252625B (zh) * | 2022-08-11 | 2024-01-26 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 一种环维黄杨星d在制备治疗非洲猪瘟的制剂中的应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1709232A (en) * | 1927-12-19 | 1929-04-16 | James J Richardson | Steering mechanism |
FR1546478A (fr) | 1967-01-27 | 1968-11-22 | Rhone Poulenc Sa | Nouveaux dérivés de l'acide benzoyl-3 phénylacétique et leur préparation |
US4560785A (en) | 1983-03-02 | 1985-12-24 | Ss Pharmaceutical Co., Ltd. | Phenylacetic ester derivatives and process for preparing the same |
DE3324193A1 (de) * | 1983-07-05 | 1985-01-17 | Troponwerke Gmbh & Co Kg | Depot-antiphlogistika |
US6217911B1 (en) * | 1995-05-22 | 2001-04-17 | The United States Of America As Represented By The Secretary Of The Army | sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres |
GB9118149D0 (en) * | 1991-08-22 | 1991-10-09 | Enzymatix Ltd | Araylalkanoic acid resolution |
DE69818093T2 (de) * | 1997-12-03 | 2004-06-09 | Merck & Co., Inc. | Langwirkende, injizierbare, formulierungen enthaltend rizinusöl |
JP2002510336A (ja) * | 1998-04-11 | 2002-04-02 | エレカッパ・ユウロテラピッチ・ソシエタ・ペル・アチオニ | 水溶性ケトプロフェン塩を含有する薬学的調製物及びその使用方法 |
US7666914B2 (en) * | 2004-06-03 | 2010-02-23 | Richlin David M | Topical preparation and method for transdermal delivery and localization of therapeutic agents |
CN1709232A (zh) * | 2005-06-15 | 2005-12-21 | 沈阳药科大学 | 含有酮洛芬或酮洛芬酯的注射用脂质微球及其制备工艺 |
WO2008057780A2 (en) * | 2006-10-27 | 2008-05-15 | Noven Pharmaceuticals, Inc. | Transdermal delivery of ketoprofen polar derivatives |
MX2011005217A (es) * | 2008-11-19 | 2011-06-01 | Merial Ltd | Formulaciones que comprenden ceftiofur y cetoprofeno o ceftiofur y alcohol bencilico. |
FR2950533B1 (fr) | 2009-09-28 | 2012-01-13 | Maco Pharma Sa | Formulation liquide, stable, prete a l'emploi de ketoprofene |
CN102648897A (zh) * | 2012-04-28 | 2012-08-29 | 东华大学 | 一种酮洛芬高分子前药聚合物微球及其制备方法 |
MX2016007869A (es) * | 2013-12-16 | 2016-10-07 | Zoetis Services Llc | Composiciones de ketoprofeno de accion prolongada. |
-
2014
- 2014-12-15 MX MX2016007869A patent/MX2016007869A/es active IP Right Grant
- 2014-12-15 AU AU2014366221A patent/AU2014366221C1/en active Active
- 2014-12-15 EP EP14827320.4A patent/EP3082762B1/en active Active
- 2014-12-15 US US15/102,020 patent/US10632095B2/en active Active
- 2014-12-15 DK DK14827320.4T patent/DK3082762T3/da active
- 2014-12-15 CN CN202110358888.6A patent/CN112843042A/zh active Pending
- 2014-12-15 CA CA2931858A patent/CA2931858C/en active Active
- 2014-12-15 NZ NZ719783A patent/NZ719783A/en unknown
- 2014-12-15 JP JP2016538550A patent/JP6306188B2/ja active Active
- 2014-12-15 WO PCT/US2014/070336 patent/WO2015095045A1/en active Application Filing
- 2014-12-15 PL PL14827320T patent/PL3082762T3/pl unknown
- 2014-12-15 RU RU2016121639A patent/RU2646829C1/ru active
- 2014-12-15 ES ES14827320T patent/ES2901706T3/es active Active
- 2014-12-15 CN CN201480068151.9A patent/CN105848638A/zh active Pending
- 2014-12-15 KR KR1020167014529A patent/KR101817028B1/ko active IP Right Grant
-
2016
- 2016-05-17 PH PH12016500910A patent/PH12016500910A1/en unknown
- 2016-06-02 CL CL2016001350A patent/CL2016001350A1/es unknown
-
2017
- 2017-11-30 JP JP2017230460A patent/JP2018058880A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US10632095B2 (en) | 2020-04-28 |
JP2018058880A (ja) | 2018-04-12 |
MX2016007869A (es) | 2016-10-07 |
US20160303065A1 (en) | 2016-10-20 |
AU2014366221C1 (en) | 2019-10-03 |
EP3082762B1 (en) | 2021-11-17 |
KR20160078491A (ko) | 2016-07-04 |
AU2014366221B2 (en) | 2019-06-13 |
PH12016500910A1 (en) | 2016-06-20 |
AU2014366221A1 (en) | 2016-05-26 |
CA2931858A1 (en) | 2015-06-25 |
RU2016121639A (ru) | 2018-01-23 |
BR112016012235A8 (pt) | 2018-01-30 |
CN105848638A (zh) | 2016-08-10 |
CN112843042A (zh) | 2021-05-28 |
WO2015095045A1 (en) | 2015-06-25 |
KR101817028B1 (ko) | 2018-01-09 |
JP6306188B2 (ja) | 2018-04-04 |
BR112016012235A2 (pt) | 2017-08-08 |
ES2901706T3 (es) | 2022-03-23 |
JP2016539997A (ja) | 2016-12-22 |
DK3082762T3 (da) | 2021-12-06 |
NZ719783A (en) | 2017-01-27 |
EP3082762A1 (en) | 2016-10-26 |
RU2646829C1 (ru) | 2018-03-07 |
PL3082762T3 (pl) | 2022-02-14 |
CA2931858C (en) | 2018-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018003754A1 (es) | Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo. | |
SV2017005461A (es) | Benzamidas sustituidas con 1,3-tiazol-2-ilo | |
IL287731A (en) | A prolonged-release preparation for administration by injection for the treatment of arthritis and pain as a result | |
CL2016000153A1 (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
CL2016001547A1 (es) | Composiciones para el cuidado oral | |
PE20151778A1 (es) | Formulacion combinada de dos compuestos antivirales | |
CL2018000222A1 (es) | Nueva combinación para el uso en el tratamiento del cáncer | |
CL2016001350A1 (es) | Composiciones de ketoprofeno de accion prologanda. | |
CL2016001609A1 (es) | Composiciones farmacéuticas que comprenden azd9291. | |
BR112015015891A8 (pt) | Composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica | |
ECSP17038893A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
CL2015002433A1 (es) | Imidazopiridazinas sustituidas | |
CL2015003507A1 (es) | Beta-caseína a2 y prevención de inflamación del intestino | |
CR20150653A (es) | Compuestos nuevos para el tratamiento del cáncer | |
NI201600006A (es) | Pirazolo-piridinaminas sustituidas | |
ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
AR095398A1 (es) | Formulaciones con oxidación reducida | |
CL2016001130A1 (es) | Composiciones sólidas de triglicéridos y usos de estas | |
CL2016001570A1 (es) | Uso de un antagonista de receptores de opioides con actividad %u039a y vortioxetina para el tratamiento de trastorno depresivo con características melancólicas | |
ECSP16086232A (es) | (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
AR106415A1 (es) | Composición farmacéutica para el tratamiento del dolor | |
ES2536842T3 (es) | Composición farmacéutica para el tratamiento del cáncer | |
CO7170180A2 (es) | Composición farmacéutica inyectable de dexketoprofeno y tramadol | |
CL2015003211A1 (es) | Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio. | |
CL2016002653A1 (es) | Combinación farmacéutica que comprende brexpiprazol y nalmefeno; composición farmacéutica que los comprende; kit farmacéutico; y uso de la combinación para la prevención y tratamiento de un trastorno relacionado con sustancias como el alcohol. |